Work

P01.04 Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.328

Authors: P. Jänne, C. Baik, H. Hayashi, W. Su, Z. Qi, K. Enomoto, M. Karnoub, C. Yu, Y. Qiu, H.A. Yu

Institutions: Dana-Farber Cancer Institute, Seattle Cancer Care Alliance, Kindai University Hospital, National Cheng Kung University Hospital, Daiichi Sankyo (United States), Daiichi-Sankyo (Japan), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3137598529

Cites:

Cited by:

Related to: 10